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Background. Inadequate bowel movements might be associated with an increase in intracranial pressure in neurosurgical patients.
In this study we investigated the influence of a structured application of laxatives and physical measures following a strict standard
operating procedure (SOP) on bowel movement, intracranial pressure (ICP), and length of hospital stay in patients with a serious
acute cerebral disorder. Methods. After the implementation of the SOP patients suffering from a neurosurgical disorder received
pharmacological and nonpharmacological measures to improve bowel movements in a standardized manner within the first 5
days after admission to the intensive care unit (ICU) starting on day of admission. We compared mean ICP levels, length of
ICU stay, and mechanical ventilation to a historical control group. Results. Patients of the intervention group showed an adequate
defecation pattern significantly more often than the patients of the control group. However, this was not associated with lower ICP
values, fewer days of mechanical ventilation, or earlier discharge from ICU. Conclusions. The implementation of a SOP for bowel
movement increases the frequency of adequate bowel movements in neurosurgical critical care patients. However, this seems not
to be associated with reduced ICP values.
1. Introduction
Motility disorders and disturbed defecation pattern are an
important everyday challenge in intensive care practice. Pro-
longed periods of analgosedation, as it is often necessary after
traumatic brain injury (TBI) or subarachnoid hemorrhage
(SAH), may lead to insufficient bowel movement and even
a state resembling paralytic ileus.This can lead to an increase
in intra-abdominal pressure (IAP) and potentially result in
an intracranial pressure (ICP) elevation [1]. In addition,
an insufficient defecation rate is possibly associated with
prolonged ventilation, increased rate of bacterial infection,
and a higher mortality rate [2–8]. However, high-rate or
high-volume defecations result in increased nursing efforts
and potentially an increased patient risk due to dehydration
[9, 10] and more frequent positioning maneuvers that could
subsequently lead to increased ICP especially in patients with
acute brain injury.
Until now no consistent regime has been implemented
to optimize defecation patterns in ICU patients, especially
in neurosurgical patients where it might be of advantage
to have controlled defecation patterns. Therefore a standard
operating procedure (SOP) dealing with the stimulation of
bowel movements and the regulation of defecation pattern
was implemented in our 10-bed neurointensive care unit.
This SOP included drug-based as well as non-drug-related
procedures for patients with acute severe cerebral disorder
with expected prolonged sedation and ventilation need.
The aim of the present preliminary study with before-
and-after design was to investigate if the implementation of a
SOP concerning the stimulation of bowel movements has the
ability to improve regularity of defecation pattern in patients
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with acute severe cerebral injuries. Furthermore we wanted
to assess the influence of this SOP on ICP levels, ventilator
dependency, and the length of ICU stay. The results of the
intervention group were compared with a historical control
group, in which promotility drugs were given only following
clinical assessment and the attending physician’s estimation
of the patient’s condition.
2. Methods
The study was approved by the ethical care committee of the
University of Regensburg (approval number 12-101-0240).
We implemented the promotility bundle consisting of a
daily increasing combination of pharmacological and non-
pharmacological interventions for 5 days starting on day of
admission (for details see Table 1) in our ICU onMay 1, 2012.
Criteria for being treated due to the SOP were age older
than 18 years, a severe brain injury such as TBI, SAH, or
intracerebral hemorrhage (ICH), or other serious cerebral
disorders with need for continuous ICP monitoring and
that continuing analgosedation and invasive ventilation for
more than three days was estimated to be necessary by the
attending physician on admission. Exclusion criteria were age
under 18 years, pregnancy, severe gastrointestinal diseases, no
ICPmonitoring, no brain injury, or estimated shorter periods
of analgosedation.
The SOP was stored in our PDMS (MetaVision Suite,
iMDsoft), and once activated it always had the same sequence
as stated in Table 1. The ICU staff was informed about the
SOP and the handling of the intervention bundle prior to
implementation.
After implementation of the SOP, patients meeting the
inclusion criteria were consecutively treated with the inter-
vention bundle betweenMay 2012 and June 2013. In a before-
and-after study, this “intervention group” was then compared
with a historical patient population receiving promotility
drugs in a nonstandardized fashion. This control group was
recruited out of patients who had been admitted to our ICU
before implementation of the SOP between August 2008 and
April 2012. All patients older than 18 years with acute serious
cerebral disorder and excluded pregnancy who had needed
analgosedation and invasive ventilation for more than three
days as well as invasive measurement of ICP were included.
For analgosedation, propofol, ketamine, midazolam, and
sufentanil were used in both groups, dose-tailored to the
assessment of the attending intensivist. For circulation
maintenance norepinephrine was used as first-line vaso-
pressor. The vasopressor dose was adjusted individually
to maintain adequate cerebral perfusion pressure (CPP)
for each patient. Nutritional support was given according
to the guidelines of the German Society for Nutrition
(DGEM 2007, http://www.dgem.de/) and the European Soci-
ety for Clinical Nutrition and Metabolism (ESPEN 2005;
http://www.espen.org/). Depending on the residual gastric
volume of the previous day, the amount of ordered enteral
nutrition was either reduced or retained or increased (up
to maximum target volume) on the following day. In all
included patients ICP was continuously monitored using the
Neurovent ICP probe by Raumedic.
Table 1: SOP: promotility procedures for adult patients with acute
severe brain disorder and expectable prolonged ventilation for more
than 3 days.
Procedures/promotility drugs
Day 1 =
admission
day
No procedures/drugs
Day 2
(i) Colon massage + physical therapy
(ii) Bisacodyl 10mg supp. 1x/day
(iii) Lactulose 10mL p.o. 2x/day
(iv) Clyster 50mL 1x/day
(v) Sodium picosulfate 10 gtt p.o. 1x/day
Day 3
(i) Colon massage + physical therapy
(ii) Lactulose 10mL p.o. 2x/day
(iii) Naloxone 4mg p.o. 3x/day
(iv) Sodium picosulfate 20 gtt p.o. 1x/day
(v) Rhizine oil 20mL p.o. 1x/day
Day 4
(i) Colon massage + physical therapy
(ii) Return-flow enema 1x/day
(iii) Lactulose 10mL p.o. 2x/day
(iv) Naloxone 4mg p.o. 3x/day
(v) Neostigmine-infusion 1.5mg 0.25mg/h i.v. 1x/day
Day 5
(i) Colon massage + physical therapy
(ii) Return-flow enema 1x/day
(iii) Lactulose 10mL p.o. 2x/day
(iv) Naloxone 4mg p.o. 3x/day
(v) Neostigmine-infusion 1.5mg 0.25mg/h i.v. 1x/day
Deescalation after adequate defecation to the following
(i) Lactulose 10mL p.o. 2x/day (8:00 a.m. + 8:00 p.m.)
(ii) For opioid use: naloxone 4mg p.o. 3x/day (8:00 a.m. +
4:00 p.m. + 12:00 p.m.)
(iii) Simethicone if necessary 5mL p.o. 4x/day (2:00 a.m. +
8:00 a.m. + 2:00 p.m. + 8:00 p.m.)
For each study day the following data were extracted from
the PDMS: gut motility parameters (defecation frequency,
stool volume, and consistency), applied promotility drugs
(dosage and ordering schedule), nonpharmacological pro-
motility procedures, analgosedation and circulatory-support
parameters (mean daily dosage), ICP levels (mean daily
values), daily amount of enteral nutrition, and fluid balances.
In addition, duration of mechanical ventilation and length of
ICU stay were documented.
The defecation pattern was recorded separately for each
of the 5 study days (0:00 a.m. to 11:59 p.m.). A cumulative
stool volumeofmore than 150mL/24 and less than 500mL/24
was defined as adequate, and a cumulative stool volume
of less than 150mL per day was insufficient. More than
500mL per day, liquid stool consistency, or a daily defecation
frequency of more than 3 was judged excessive. According
to these criteria, patients were divided into two groups:
group 1 (“adequate defecation”) consisted of patients, whose
defecation patternwas adequate formore than one daywithin
the study period and who never showed excessive defecation.
Group 2 (“inadequate defecation”) included all patients,
whose defecation patterns were insufficient or excessive,
respectively. Additionally patients with at least one day of
excessive defecation were recorded separately.
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Table 2: Standard care and intervention group. Adequate defecation was observed significantlymore often in the intervention group, whereas
excessive defecation was seen as frequent in intervention group and in standard care group.
Total patients
𝑁
Female
𝑛 (%)
Male
𝑛 (%)
Mean age
[years] (SD)
Adequate
defecation
𝑛 (%)
Excessive
defecation
𝑛 (%)
Standard care group 109 43 (39.4) 66 (60.6) 52.6 (15.5) 9 (8.3) 7 (6.4)
Intervention group 37 13 (35.1) 24 (64.9) 46.6 (19.7) 9 (24.3) 2 (5.4)
P 0.01
OR 3.6 P 0.59
𝑛: number, SD: standard deviation, and OR: odds ratio.
Table 3: Mean daily ICP values.
MW
Standard care group
(mmHg)
MW
Intervention group
(mmHg)
MD
(mmHg) 95% CI 𝑃 level
Day 1 10.6 10.0 0.6 −1.7; 2.8 0.60
Day 2 11.2 12.0 −0.8 −2.2; 0.6 0.27
Day 3 11.4 11.9 −0.5 −1.9; 0.8 0.43
Day 4 11.3 10.7 0.6 −0.9; 2.0 0.44
Day 5 12.4 10.4 2.0 −0.5; 4.4 0.12
MW: mean value, MD: mean difference, and CI: confidence interval.
Statistical analysis was done using IBM SPSS Statistics
Version 21. Categorical data were displayed according to their
distribution frequency. Statistical significance was calculated
using Fisher’s exact test or chi-square test (significance
was supposed when 𝑃 level was < 0.05), respectively. An
odds ratio (OR) was calculated if reasonable. Metric data
were analyzed using either Student’s 𝑡-test or Welch’s test
(significance was supposed when 𝑃 level was < 0.05).
3. Results
During the period between May 2012 and June 2013 a total
of 37 patients (13 female, 24 male, average age 46.6 years,
SD 19.7 years) were included in the intervention group and
treated according to the SOP. The historical comparison
group (“standard care group”) consisted of 109 patients (43
female, 66 male, average age 52.6 years, SD 15.5 years). SAH
was the main diagnosis within the standard care group (47
patients). 35 patients suffered from severe traumatic brain
injury, 3 frommeningoencephalitis, 7 from cerebral ischemia,
and 13 from other types of intracranial hemorrhage, and 2
presented with sinus venous thrombosis, 1 with an intrac-
erebral tumor, and 1 with an arteriovenous malformation
(AVM). The intervention group consisted of 8 SAH patients,
19 severe brain trauma patients, 8 patients with other types
of intracerebral hemorrhage, 1 patient with an intracerebral
tumor, and 1 patient with an AVM. In both groups patients
suffering from the three main diagnoses accounted for 87–
95% of the group volume.
Propofol, midazolam, and ketamine were given contin-
uously for sedation and sufentanil was used for analgesia.
No significant dose differences for each hypnotic as well
as the opioid were found between the standard care and
the intervention group (Figure 1). The mean daily dose of
norepinephrine did not significantly differ between the two
groups either (Figure 2).
Themain difference between the two groups was found in
the defecation pattern. Nine out of 37 (24.3%) patients of the
intervention group showed an adequate defecation pattern
within the 5-day study period compared to only 9 out of 109
(8.3%) in the standard group. This difference was statistically
significant (𝑃 0.01, OR 3.6, Table 2). Excessive defecation was
equally distributed and had been seen in 2 of 37 patients
(5.4%) of the intervention group and in 7 of 109 patients of
the standard group (6.4%, 𝑃 0.59, Table 2).
There was no significant difference in the mean daily
value of ICP between the two study groups, although we
observed as mentioned an adequate defecation pattern sig-
nificantly more often in the intervention group (Table 3).
The daily fluid balances (calculation: mean daily par-
enteral and enteral influx minus mean daily efflux by urine,
stool, and other losses) and amounts of given enteral nutrition
did not differ between the two groups either during the study
period (Tables 4 and 5).
Standard care group patients had to be ventilated
mechanically for an average of 14.1 days, whereas intervention
group patients only were ventilator-dependent for 12.1 days.
This was a mean difference of 2.0 days (95% CI −0.4–4.4)
between the groups which, however, did not reach statistical
significance (𝑃 0.10). The mean length of ICU stay was
24.9 days in the standard care group and 26.1 days in the
intervention group, respectively. Despite the 1.1-day shorter
ICU stay (95% CI −5.2–2.9) in the standard care group, there
was also no statistical significance (𝑃 0.58).
Overall, regardless of the group affiliation, 18 patients
revealed an adequate defecation pattern.However, ICP values
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Table 4: Daily fluid balance.
MW
Standard care group
(L)
MW
Intervention group
(L)
MD
(L) 95% CI 𝑃 level
Day 1 0.76 0.91 −0.15 −0.73; 0.42 0.59
Day 2 1.20 1.40 −0.20 −0.91; 0.51 0.57
Day 3 0.89 0.87 0.01 −0.42; 0.45 0.95
Day 4 0.46 0.75 −0.29 −0.76; 0.17 0.21
Day 5 0.21 0.33 −0.12 −0.58; 0.33 0.60
MW: mean value, MD: mean difference, and CI: confidence interval.
Table 5: Daily amount of given enteral nutrition.
MW
Standard care group
(mL)
MW
Intervention group
(mL)
MD
(mL) 95% CI 𝑃 level
Day 1 21.7 4.3 17.4 −0.1; 34.8 0.05
Day 2 221.2 267.9 −46.7 −145.1; 51.8 0.35
Day 3 484.9 478.1 6.8 −129.2; 142.8 0.92
Day 4 674.8 837.1 −162.3 −348.0; 23.4 0.09
Day 5 790.0 976.4 −186.4 −414.5; 41.8 0.11
MW: mean value, MD: mean difference, and CI: confidence interval.
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Figure 1: No significant differences in the mean daily dose between the standard care and the intervention group were seen for propofol,
sufentanil, midazolam, and ketamine.
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Figure 2: Box plot depicting the mean daily dose of norepinephrine
in each of both groups. There was also no significant difference
between the two groups.
during the first 5 days of ICU staywere comparable in patients
with and without adequate defecation. The amount of given
enteral nutrition was also comparable between “defecators”
and “nondefecators.” Finally there was no significant differ-
ence in the duration of mechanical ventilation (14.7 versus
13.5, 95% CI −5.2; 2.7, 𝑃 0.52) or ICU stay (25.3 versus 25.2
days, 95% CI −6.0; 5.7, 𝑃 0.97) between patients showing
adequate or inappropriate defecation pattern.
4. Discussion
In the present study we could demonstrate that the install-
ment of a SOP for promotility drugs and nonpharmacological
interventions in analgosedated patients with an acute serious
cerebral disorder led to a significantly improved defecation
pattern when compared to a historical patient collective.
Despite this promising finding we could not show any
positive effects of the improved defecation pattern on ICP,
length of ICU stay, or ventilator dependency.
SOPs intend to assist in routine daily practice and to guar-
antee the realization of standards in the critical care setting.
Currently, there is a lack of high-grade evidence guidelines
dealing with gut motility and laxative regulation in intensive
care patients. To improve bowel movement we implemented
a SOP bundle consisting of drug ordering sequences and
nonpharmacological measures on our neurosurgical ICU.
To date only few investigations examined the effectiveness
of particular promotility drugs in the critically ill patients
[4, 11–14] and were not capable of leading to a conclusive
evidence-based strategy. Therefore we based our SOP mainly
on theoretical considerations. In contrast to use of only a
single treatment we intended to use synergies with step-
by-step increasing intensity if defecation was not sufficient.
Implementing the SOP into the PDMS provided the option
to order the standard treatment bundle automatically at ICU
admission for the current and the following days. Automated
PDMS-based ordering systems are already established in
our and other ICUs, for example, on the field of weaning
protocols [15, 16], and are usually followed precisely by the
ICU staff. The literature-based prevalence of constipation
in critically ill patients varies from 16 to 84% [6–8, 17–
19] and from 15.7 to 38% for diarrhea, respectively [8, 17].
Inhomogeneous study populations may explain the broad
prevalence spread but the lack of an integrative definition of
regular bowel movement or defecation might take the lion’s
share of the problem; for example, for diarrhea one can find
33 different definitions [20]. Hence we used a study definition
of adequate or excessive defecation that, from our point of
view, appears reasonable in clinical daily routine. Relating
to this definition our study elicited that the implementation
of a SOP for the use of promotility drugs and nonphar-
macological promotility therapies significantly improved the
defecation pattern of neurosurgical ICU patients. However,
an excessive amount or frequency of stool was not seen in
the intervention group patients. In contrast to our results a
recently published study by Knowles et al. did not find an
effect of a “bowel management protocol” on the incidence
of constipation or diarrhea [21]. The authors presumed an
insufficient anchorage of the protocol in daily practice being
the main reason for the lacking effect. In our study this
“transformation problem” was eliminated by using a highly
automated ordering process via PDMS. In addition, the fact
that both groups showed no significant difference in dose
rates of sedatives and analgetics, especially opioids, as well as
vasopressors which are clearly associated with constipation
[5, 22], eliminates a potential effect of deeper analgosedation
or more intensive vasopressor therapy on the defecation
pattern in this study, even if the SOP contained no dose
proposals for these topics. In addition, differing fluid balances
or amounts of given enteral nutrition as potential influencing
factors could also be excluded.
An association between extracranial influences on ICP
such as elevated intra-abdominal pressure (IAP) has been
repeatedly described [1]. Data from the literature dealing
with the development of elevated IAP levels over time in
critically ill patients is scarce and inhomogeneous [23–25] but
inadequate defecation is one reason for increased IAP. Inter-
estingly we could not establish a positive correlation between
improved defecation pattern in the intervention group and
ICP values. Despite the findings that prolonged constipation
might lead to an elevation in IAP, this is not necessarily the
case. Due to the fact that we did not measure IAP we cannot
conclude that constipation in our patient collective led to an
increase in IAP, thus influencing ICP as described previously
[1, 26–29]. In addition, the relatively low mean ICP values
in our collectives might represent the fact that the brain
autoregulation as well as its mechanisms to compensate for
mildly elevated intra-abdominal compartment pressure was
still intact. It is also likely that within the first days of ICU stay
in patients without serious intra-abdominal disorder the IAP
does not rise to a level that might be capable of influencing
ICP.
6 Critical Care Research and Practice
The duration of mechanical ventilation and the length of
ICU stay did not differ between the groups. A shortening
of mechanical ventilation and ICU stay was described if
a regular defecation pattern could be achieved within the
first six days after ICU admission [4, 5]. Constipation in
contrast was associated with longer ICU stay and a higher
weaning failure rate [2, 7]. It is again likely that the chosen
investigation period in our study was too short to answer
questions concerning the duration of mechanical ventilation
or ICU stay sufficiently and length of ventilation and ICU stay
depend on various other factors like developing pneumonia
or delirium.
Overall our study has some shortcomings. Even if the
incidence of adequate defecation pattern was statistically
significantly higher in the intervention group only 24.3% of
the patients in the intervention group had adequate defeca-
tion. This is a relatively low percentage, giving rise to the
thought that either the SOP might be insufficient to reach
the targeted goal of adequate defecation or our definition
was too tight. From a clinical standpoint it would have
possibly been sufficient if a patient had shown an adequate
defecation on only one day of the whole study period. In
addition, the first 5 days after ICU admission might reflect
the critical initial phase in brain injury with often the
requirement for deep analgosedation and circulatory support
but may not reflect the most decisive period for the impact
of bowel motility disturbances on ICP and the duration of
ICU stay or mechanical ventilation. Thus additional studies
using IAP measurement as well as longer observation times
are needed to evaluate influence of defecation pattern on
IAP and ICP. The latter should also been investigated in
patients with higher ICP levels that might have compromised
compensation mechanisms.
5. Conclusion
Our study showed that a standardized ordering bundle of
promotility drugs and nonpharmacological interventions,
applied immediately on ICU admission for the first 5 days,
is capable of improving defecation pattern in critically ill
patients suffering from acute severe brain disorder. However,
there was no influence of the SOP on the mean ICP values,
the duration of mechanical ventilation, or the length of ICU
stay.More studies are necessary to evaluate the effect of bowel
movements on IAP and ICP in neurosurgical critically ill
patients.
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